Google
×
NASDAQ INVESTOR RELATIONS · News & Events RELEASES & PRESENTATIONS · Stock STOCK QUOTE & MORE · Financials QUARTERLY RESULTS & MORE · ESG · Governance CORPORATE ...
People also ask
A: Synergy stockholders may call Synergy Investor Relations at 212-297-0020. Callisto stockholders may call Callisto Investor Relations at 212-297-0010.
A live webcast of the presentation will be accessible through the Investor Relations section of the company's website at www.synergypharma.com. A replay of ...
Feb 26, 2019 · Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc. ; Investor Contact: Media Contact: ; Arthur Shannon. Lainie Keller ; arthur ...
... investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such ...
Synergy Pharmaceuticals, Inc. (Nasdaq: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced that it has engaged.
A high-level overview of Synergy Pharmaceuticals, Inc. (SGYP-OLD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, ...
Missing: relations | Show results with:relations
Investor Relations · Latest Company News · Latest Financial Results · Selected Financial Highlights · Latest Annual Filing · Email Alerts · Stock Snapshot · Creating a ...
Missing: sgyp | Show results with:sgyp
Dec 12, 2018 · InvestorPlace - Stock Market News, Stock Advice & Trading TipsSynergy Pharmaceuticals (NASDAQ: SGYP ) has filed for Chapter 11 bankruptcy in ...
If you purchased shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), you have certain options and you should contact the Shareholders Foundation, inc. To have ...
Missing: relations | Show results with:relations